These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 15976135)
21. The role of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma in diabetes risk. Tönjes A; Stumvoll M Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):410-4. PubMed ID: 17563457 [TBL] [Abstract][Full Text] [Related]
22. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome. Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841 [TBL] [Abstract][Full Text] [Related]
23. Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma2 gene on rosiglitazone response in type 2 diabetes. Kang ES; Park SY; Kim HJ; Kim CS; Ahn CW; Cha BS; Lim SK; Nam CM; Lee HC Clin Pharmacol Ther; 2005 Aug; 78(2):202-8. PubMed ID: 16084854 [TBL] [Abstract][Full Text] [Related]
24. Association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma2 gene with small dense low-density lipoprotein in the general population. Hamada T; Kotani K; Tsuzaki K; Sano Y; Murata T; Tabata M; Sato S; Sakane N Metabolism; 2007 Oct; 56(10):1345-9. PubMed ID: 17884443 [TBL] [Abstract][Full Text] [Related]
26. A novel -192c/g mutation in the proximal P2 promoter of the hepatocyte nuclear factor-4 alpha gene (HNF4A) associates with late-onset diabetes. Ek J; Hansen SP; Lajer M; Nicot C; Boesgaard TW; Pruhova S; Johansen A; Albrechtsen A; Yderstraede K; Lauenborg J; Parrizas M; Boj SF; Jørgensen T; Borch-Johnsen K; Damm P; Ferrer J; Lebl J; Pedersen O; Hansen T Diabetes; 2006 Jun; 55(6):1869-73. PubMed ID: 16731855 [TBL] [Abstract][Full Text] [Related]
27. The minor allele of the PPARgamma2 pro12Ala polymorphism is associated with lower postprandial TAG and insulin levels in non-obese healthy men. Helwig U; Rubin D; Kiosz J; Schreiber S; Fölsch UR; Nothnagel M; Döring F; Schrezenmeir J Br J Nutr; 2007 May; 97(5):847-54. PubMed ID: 17408525 [TBL] [Abstract][Full Text] [Related]
28. Association between functional FABP2 promoter haplotype and type 2 diabetes. Li Y; Fisher E; Klapper M; Boeing H; Pfeiffer A; Hampe J; Schreiber S; Burwinkel B; Schrezenmeir J; Döring F Horm Metab Res; 2006 May; 38(5):300-7. PubMed ID: 16718625 [TBL] [Abstract][Full Text] [Related]
29. [Leptin level and the PPARgamma2 Pro12Ala and Pro115Gln polymorphisms in women with functional hyperandrogenism. Preliminary report]. Bidzińska-Speichert B; Demissie M; Tworowska U; Slezak R; Dobosz T; Bednarek-Tupikowska G; Milewicz A Przegl Lek; 2005; 62(9):833-7. PubMed ID: 16541712 [TBL] [Abstract][Full Text] [Related]
30. A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians. Muller YL; Bogardus C; Beamer BA; Shuldiner AR; Baier LJ Diabetes; 2003 Jul; 52(7):1864-71. PubMed ID: 12829658 [TBL] [Abstract][Full Text] [Related]
31. Genetic analysis of the estrogen-related receptor alpha and studies of association with obesity and type 2 diabetes. Larsen LH; Rose CS; Sparsø T; Overgaard J; Torekov SS; Grarup N; Jensen DP; Albrechtsen A; Andersen G; Ek J; Glümer C; Borch-Johnsen K; Jørgensen T; Hansen T; Pedersen O Int J Obes (Lond); 2007 Feb; 31(2):365-70. PubMed ID: 16755280 [TBL] [Abstract][Full Text] [Related]
32. Effect of the peroxisome proliferators-activated receptor (PPAR) gamma 3 gene on BMI in 1,210 school students from Morelos, Mexico. Chen L; Velasco Mondragón HE; Lazcano-Ponce E; Collins A; Shugart YY Pac Symp Biocomput; 2006; ():467-77. PubMed ID: 17094261 [TBL] [Abstract][Full Text] [Related]
33. Novel Genetic Variants of Wu L; Song Y; Zhang Y; Liang B; Deng Y; Tang T; Ye YC; Hou HY; Wang CC Front Endocrinol (Lausanne); 2020; 11():499788. PubMed ID: 33551986 [TBL] [Abstract][Full Text] [Related]
34. The Pro12Ala and C-681G variants of the PPARG locus are associated with opposing growth phenotypes in young schoolchildren. Cecil JE; Fischer B; Doney AS; Hetherington M; Watt P; Wrieden W; Bolton-Smith C; Palmer CN Diabetologia; 2005 Aug; 48(8):1496-502. PubMed ID: 16007414 [TBL] [Abstract][Full Text] [Related]
35. Genetics and Clinical Characteristics of PPARγ Variant-Induced Diabetes in a Chinese Han Population. Gong S; Han X; Li M; Cai X; Liu W; Luo Y; Zhang SM; Zhou L; Ma Y; Huang X; Li Y; Zhou X; Zhu Y; Wang Q; Chen L; Ren Q; Zhang P; Ji L Front Endocrinol (Lausanne); 2021; 12():677130. PubMed ID: 34764936 [TBL] [Abstract][Full Text] [Related]
36. Relationship between two sequence variations in the gene for peroxisome proliferator-activated receptor-gamma and plasma homocysteine concentration. Health in men study. Golledge J; Norman PE Hum Genet; 2008 Feb; 123(1):35-40. PubMed ID: 17999084 [TBL] [Abstract][Full Text] [Related]
37. Body Mass Index in Pregnancy Does Not Affect Peroxisome Proliferator-activated Receptor Gamma Promoter Region (-359 to -260) Methylation in the Neonate. Casamadrid V; Amaya CA; Mendieta ZH Ann Med Health Sci Res; 2016; 6(1):38-43. PubMed ID: 27144075 [TBL] [Abstract][Full Text] [Related]
38. Genetics of the metabolic complications of obesity. Lewis JP; Shuldiner AR Prog Mol Biol Transl Sci; 2010; 94():349-72. PubMed ID: 21036331 [No Abstract] [Full Text] [Related]
39. Association between PPAR-γ2 Pro12Ala polymorphism and obesity: a meta-analysis. Yao YS; Li J; Jin YL; Chen Y; He LP Mol Biol Rep; 2015 Jun; 42(6):1029-38. PubMed ID: 25502405 [TBL] [Abstract][Full Text] [Related]
40. Genotype-phenotype associations in obesity dependent on definition of the obesity phenotype. Kring SI; Larsen LH; Holst C; Toubro S; Hansen T; Astrup A; Pedersen O; Sørensen TI Obes Facts; 2008; 1(3):138-45. PubMed ID: 20054173 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]